INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

LAESSEALSQ Corp

CIK 0001951222

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 26
Max Insider Score32
Connections10with evidence

LAES · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Telecommunications & technologySEC SIC 3674 · Semiconductors & Related Devices · Nov 4, 2026
  • ← Insider ofevidence
    Fergusson David AlexanderDirector · Oct 6, 2026
  • ← Insider ofevidence
    Pellaton Eric AdrienDirector · Oct 6, 2026
  • ← Insider ofevidence
    Ward PeterDirector · Jun 18, 2026
7
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M
—
20.0K sh
Nov 2, 2026
Nov 3, 2026
traded Nov 2, 2026
+1d
SEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
50.0K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

13
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$48K
35.0K sh
Nov 3, 2026Nov 3, 2026
traded Nov 3, 2026
+0dSEC FORM 4

Evidence

7
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$200
20.0K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$350
35.0K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
35.0K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

16
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$86K
35.0K sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
50.0K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

19
PA
Pellaton Eric AdrienDirector
LAESSEALSQ Corp
Grant or award
A—
14.1K sh
Sep 25, 2026Oct 6, 2026
traded Sep 25, 2026
+11dSEC FORM 4

Evidence

9
WP
Ward PeterDirector
LAESSEALSQ Corp
Grant or award
A—
4,686 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC FORM 4

Evidence

9
WP
Ward PeterDirector
LAESSEALSQ Corp
Grant or award
A—
3,582 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC FORM 4

Evidence

19
FA
Fergusson David AlexanderDirector
LAESSEALSQ Corp
Grant or award
A—
14.1K sh
Sep 25, 2026Oct 6, 2026
traded Sep 25, 2026
+11dSEC FORM 4

Evidence

19
FA
Fergusson David AlexanderDirector
LAESSEALSQ Corp
Grant or award
A—
3,424 sh
Sep 25, 2026Oct 6, 2026
traded Sep 25, 2026
+11dSEC FORM 4

Evidence

19
PA
Pellaton Eric AdrienDirector
LAESSEALSQ Corp
Grant or award
A—
10.7K sh
Sep 25, 2026Oct 6, 2026
traded Sep 25, 2026
+11dSEC FORM 4

Evidence

13
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$36K
15.0K sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC FORM 4

Evidence

9
WP
Ward PeterDirector
LAESSEALSQ Corp
Option exercise
M—
13.6K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC FORM 4

Evidence

9
WP
Ward PeterDirector
LAESSEALSQ Corp
Option exercise
M—
353.1K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC FORM 4

Evidence

27
WP
Ward PeterDirector
LAESSEALSQ Corp
Tax withholding
F$296K
96.5K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC FORM 4

Evidence

21
WP
Ward PeterDirector
LAESSEALSQ Corp
Option exercise
M$3,667
366.7K sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC FORM 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$502
143 sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC FORM 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$20K
5,582 sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC FORM 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$37K
10.0K sh
Jun 2, 2026Jun 3, 2026
traded Jun 2, 2026
+1dSEC FORM 4

Evidence

7
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
60.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

26
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$53K
15.0K sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

13
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$16K
4,689 sh
May 27, 2026May 29, 2026
traded May 27, 2026
+2dSEC FORM 4

Evidence

20
MC
Moreira CarlosDirector, Chief Executive Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$15K
4,139 sh
May 27, 2026May 29, 2026
traded May 27, 2026
+2dSEC FORM 4

Evidence

11
MC
Moreira CarlosDirector, Chief Executive Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$35K
10.0K sh
May 29, 2026May 29, 2026
traded May 29, 2026
+0dSEC FORM 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$35K
10.0K sh
May 29, 2026May 29, 2026
traded May 29, 2026
+0dSEC FORM 4

Evidence

31
BJ
Buonanno Franck JeanVice-President, Global Sales
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$58K
20.0K sh
May 14, 2026May 15, 2026
traded May 14, 2026
+1dSEC FORM 4

Evidence

7
BJ
Buonanno Franck JeanVice-President, Global Sales
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$200
20.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

0
BJ
Buonanno Franck JeanVice-President, Global Sales
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
20.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

23
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$47K
15.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
May 4, 2026May 4, 2026
traded May 4, 2026
+0dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
May 4, 2026May 4, 2026
traded May 4, 2026
+0dSEC FORM 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$15K
5,250 sh
Apr 24, 2026Apr 24, 2026
traded Apr 24, 2026
+0dSEC FORM 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$29K
10.0K sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC FORM 4

Evidence

3
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$31K
10.0K sh
Apr 22, 2026Apr 24, 2026
traded Apr 22, 2026
+2dSEC FORM 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$28K
10.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$30K
10.0K sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC FORM 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$27K
10.0K sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$27K
10.0K sh
Apr 17, 2026Apr 17, 2026
traded Apr 17, 2026
+0dSEC FORM 4

Evidence

0
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
130.5K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

4
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$1,305
130.5K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

0
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
130.5K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC FORM 4

Evidence

32
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$33K
15.0K sh
Apr 8, 2026Apr 9, 2026
traded Apr 8, 2026
+1dSEC FORM 4

Evidence

5
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
Apr 6, 2026Apr 9, 2026
traded Apr 6, 2026
+3dSEC FORM 4

Evidence

13
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$21K
10.0K sh
Apr 7, 2026Apr 9, 2026
traded Apr 7, 2026
+2dSEC FORM 4

Evidence

13
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$21K
10.0K sh
Apr 9, 2026Apr 9, 2026
traded Apr 9, 2026
+0dSEC FORM 4

Evidence

13
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$22K
10.0K sh
Apr 8, 2026Apr 9, 2026
traded Apr 8, 2026
+1dSEC FORM 4

Evidence

5
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
Apr 6, 2026Apr 9, 2026
traded Apr 6, 2026
+3dSEC FORM 4

Evidence

0
FA
Feuardent Moreira AndreasChief Innovation Officer
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$100
10.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC FORM 4

Evidence

32
FA
Feuardent Moreira AndreasChief Innovation Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$23K
10.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC FORM 4

Evidence

0
FA
Feuardent Moreira AndreasChief Innovation Officer
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
10.0K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC FORM 4

Evidence

13
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$24K
10.0K sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC FORM 4

Evidence

← Insider ofevidence
Moreira Carlos
Director, Chief Executive Officer · May 29, 2026
  • ← Insider ofevidence
    Enguent Jean-PierreVice President, R&DSS · Apr 9, 2026
  • ← Insider ofevidence
    Feuardent Moreira AndreasChief Innovation Officer · Apr 8, 2026
  • ← Insider ofevidence
    Buonanno Franck JeanVice-President, Global Sales · Mar 27, 2026
  • ← Insider ofevidence
    O'Hara John CharlesDirector, Chief Financial Officer · Mar 23, 2026
  • ← Insider ofevidence
    Verjus Nathalie Claude OdileCompany Secretary · Mar 19, 2026